Stefano Vavassori
For over twenty years I've worked at the intersection of basic science and the clinic, from early-stage concept and spin-off formation through fundraising, preclinical development, and IND-ready packages, into Phase I and Phase II trials. Eight of those years were spent at the University Children's Hospital Zurich, and five more across three biotech startups: Cellerys, metaLead Therapeutics, and Tiny Pharma.
In December 2025 I completed an Executive MBA at the University of Zurich, focused on digital transformation, a deliberate step to translate scientific depth into organisational decisions, not just publications. I'm Italian, and work comfortably in English, German and Italian.
Alongside consulting, I co-founded ImmunoT-yp, a functional immune biomarker platform.